MedicineOphthalmologyPharmacotherapyOcular DiseaseOcular PharmacologyVisual DisordersMedication Effects On VisionOcular ToxicologyRetinal PharmacotherapyDaily DosingDrug-induced Ocular ToxicityHydroxychloroquine TherapyHydroxychloroquine TreatmentMedication-induced Ocular ToxicityOcular Drug ToxicityRetinal Drug SafetyRetinal Toxicity Screening
Ninety-nine patients were treated with hydroxychloroquine sulfate for connective tissue diseases during a seven year period. All patients received the medication for at least one year and most were treated with a daily dosage of 400 mg. Four patients experienced toxic effects, but no patient sustained permanent loss of visual acuity. Toxicity did not seem to represent a cumulative dosage effect. Funduscopic and visual field examinations at six-month intervals are sufficient to detect the occasional adverse reactions and prevent serious retinal toxic effects when a maximum daily dosage of 400 mg is maintained.
17
RETINOPATHY FOLLOWING CHLOROQUINE THERAPY
H. E. Hobbs, Arnold Sorsby, A. Freedman · The Lancet · 1959 · 342 citations
Chloroquine retinopathy in the rhesus monkey.
A R Rosenthal, Helga Kolb, Donald R. Bergsma et al. · PubMed · 1978 · 195 citations
OCULAR DAMAGE IN CHLOROQUINE THERAPY
Ulf Nylander · Acta Ophthalmologica · 1966 · 127 citations
Chloroquine in Rheumatoid Arthritis
A. Freedman, V. L. Steinberg · Annals of the Rheumatic Diseases · 1960 · 123 citations · Full text